SENTINEL Due-Diligence Dossier

Target: PFIZER INC Requested as: Pfizer Type: company Generated: 2026-07-14T13:58:33.433Z Synthesis: deterministic Dossier ID: dsr_pfizer_7gtt9

Source integrity. 18/18 claims are backed by 20 cited public sources. 0 uncited claim(s) were dropped by the verifier. Every statement below links to a real, fetched source — nothing is inferred beyond what the cited material says.

⚠️ Risk Flags

No adverse-media or risk-lexicon signals detected in the collected evidence. This is not an all-clear — absence of signal in open sources is not absence of risk.

Identity & Background

Background (encyclopedic): Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. [E1]
Regulatory identity: Registrant: PFIZER INC · Ticker(s): PFE · SIC industry: Pharmaceutical Preparations (2834) · HQ: NEW YORK, NY [E2] (high confidence)

Financial & Regulatory Filings

Filing on record: 8-K filed 2026-06-18 — PFIZER INC [E3] (high confidence)
Filing on record: 8-K filed 2026-06-18 — PFIZER INC [E4] (high confidence)
Filing on record: 10-Q filed 2026-05-05 — PFIZER INC [E5] (high confidence)
Filing on record: 8-K filed 2026-05-05 — PFIZER INC [E6] (high confidence)
Filing on record: 8-K filed 2026-04-27 — PFIZER INC [E7] (high confidence)
Filing on record: DEF 14A filed 2026-03-12 — PFIZER INC [E8] (high confidence)

Legal, Litigation & Adverse Media

Open-web adverse-media search not run (no SERPERAPI_KEY). Litigation/sanctions coverage is limited to news + filings above._

Collection Log

Partial collection. 1 source(s) did not return data on this run (GDELT / global news: timeout). Their coverage is MISSING from this dossier, not inferred — treat the sections below as incomplete for those sources.

Source	Status	Items	Note
Wikipedia	✅ ok	1	—
SEC EDGAR	✅ ok	7	—
OpenCorporates registry	⏭️ skipped	0	set OPENCORPORATES_API_TOKEN to enable global company-registry lookups (officers, incorporation, status)
Google News	✅ ok	12	—
GDELT / global news	⌛ timeout	0	This operation was aborted (api.gdeltproject.org)
Open-web search	⏭️ skipped	0	set SERPER_API_KEY (serper.dev) to enable open-web litigation/sanctions/adverse-media search

Sources

[E1] Wikipedia — Pfizer (retrieved 2026-07-14T13:58:24Z)
[E2] SEC EDGAR — PFIZER INC — EDGAR filer profile (CIK 78003) (retrieved 2026-07-14T13:58:24Z)
[E3] SEC EDGAR — 8-K filed 2026-06-18 — PFIZER INC, published 2026-06-18 (retrieved 2026-07-14T13:58:24Z)
[E4] SEC EDGAR — 8-K filed 2026-06-18 — PFIZER INC, published 2026-06-18 (retrieved 2026-07-14T13:58:24Z)
[E5] SEC EDGAR — 10-Q filed 2026-05-05 — PFIZER INC, published 2026-05-05 (retrieved 2026-07-14T13:58:24Z)
[E6] SEC EDGAR — 8-K filed 2026-05-05 — PFIZER INC, published 2026-05-05 (retrieved 2026-07-14T13:58:24Z)
[E7] SEC EDGAR — 8-K filed 2026-04-27 — PFIZER INC, published 2026-04-27 (retrieved 2026-07-14T13:58:24Z)
[E8] SEC EDGAR — DEF 14A filed 2026-03-12 — PFIZER INC, published 2026-03-12 (retrieved 2026-07-14T13:58:24Z)
[E9] News — Notes From Poland — Polish air-traffic agency funds frozen as Pfizer enforces €1.3bn ruling for Poland's unpaid Covid vaccines - Notes From Poland, published 2026-07-11 (retrieved 2026-07-14T13:58:25Z)
[E10] News — The New Yorker — Who Will Be Blamed for the Near-Collapse of a Midtown Tower? - The New Yorker, published 2026-07-11 (retrieved 2026-07-14T13:58:25Z)
[E11] News — Bloomberg Law News — Pfizer Drops Patent Suit Over Alkem Copies of Inlyta Cancer Drug - Bloomberg Law News, published 2026-07-13 (retrieved 2026-07-14T13:58:25Z)
[E12] News — The Pharma Letter — Pfizer names Danna Breen to lead obesity discovery as Kendra Bence exits - The Pharma Letter, published 2026-07-13 (retrieved 2026-07-14T13:58:25Z)
[E13] News — The Globe and Mail — Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb - The Globe and Mail, published 2026-07-14 (retrieved 2026-07-14T13:58:25Z)
[E14] News — Yahoo Finance — Pfizer (PFE) Advances While Market Declines: Some Information for Investors - Yahoo Finance, published 2026-07-13 (retrieved 2026-07-14T13:58:25Z)
[E15] News — TipRanks — Pfizer price target lowered to $35 from $36 at Guggenheim - TipRanks, published 2026-07-13 (retrieved 2026-07-14T13:58:25Z)
[E16] News — Crain's New York — Developers’ ‘small’ failure at Pfizer tower draws big industry dispute - Crain's New York, published 2026-07-10 (retrieved 2026-07-14T13:58:25Z)
[E17] News — Seeking Alpha — Pfizer: The AI Hedge That Pays You To Stay Defensive - Seeking Alpha, published 2026-07-11 (retrieved 2026-07-14T13:58:25Z)
[E18] News — Yahoo Finance — Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap? - Yahoo Finance, published 2026-07-13 (retrieved 2026-07-14T13:58:25Z)
[E19] News — Reuters — US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight - Reuters, published 2026-07-09 (retrieved 2026-07-14T13:58:25Z)
[E20] News — AP News — New York construction scare highlights the challenges of converting offices into housing - AP News, published 2026-07-10 (retrieved 2026-07-14T13:58:25Z)

Generated by SENTINEL. Open-source intelligence for triage and lead generation. Not legal or investment advice; verify material findings against primary records before acting.